CLINICAL_TRIALS
trial_result
· 2016-05-11
Clinical Trial Update: Relative Bioavailability of Pimasertib in Cancer Patients [Phase 1]
Summary
Phase 1 study evaluating the relative bioavailability of pimasertib in cancer patients completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2016-05-11